Incyte Corporation (INCY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Incyte Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Incyte Corporation (INCY) has returned -4.71% so far this year and 55.44% over the past 12 months. Over the last ten years, INCY has returned 2.53% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Nov 4, 1993, INCY's average daily return is +0.13%, while the average monthly return is +2.65%. At this rate, your investment would double in approximately 2.2 years.

Historically, 53% of months were positive and 47% were negative. The best month was Feb 2000 with a return of +151.0%, while the worst month was Mar 2000 at -68.3%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 8 months.

On a daily basis, INCY closed higher 48% of trading days. The best single day was Jan 3, 2000 with a return of +49.4%, while the worst single day was Sep 28, 2005 at -41.0%.

Incyte Corporation has an annualized alpha of 20.90%, beta of 1.26, and R² of 0.14 versus S&P 500 Index. Calculated based on daily prices since November 05, 1993.

• This stock captured 151.78% of S&P 500 Index gains and 126.19% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.14 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

INCY ranks 84 for risk / return — in the top 84% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Incyte Corporation (INCY) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Incyte Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Incyte Corporation was 98.54%, occurring on Mar 9, 2009. Recovery took 2016 trading sessions.

The current Incyte Corporation drawdown is 38.35%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Incyte Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Incyte Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.